S5 Ep20: Sherman Spotlights Advances With RET Inhibitors in Medullary Thyroid Cancer

OncLive® On Air - Podcast készítő OncLive® On Air

Podcast artwork

Dr. Sherman discusses the incidence of RET fusions in medullary thyroid cancer and the current clinical landscape of RET inhibitors in the field.

Visit the podcast's native language site